Table 1 Patient characteristics
Patients | Total (n = 90) | % |
|---|---|---|
Gender: Female | 38 | 42% |
Male | 52 | 58% |
Age at diagnostic, median (range): | 62 years | (22–82) |
Age at SBRT, median (range): | 65 years | (23–84) |
Primary sites: Digestive | 63 | 70% |
Lung | 3 | 3.3% |
Breast | 8 | 8.9% |
Melanoma | 4 | 4.4% |
Neuro-endocrine | 3 | 3.3% |
Sarcoma | 3 | 3.3% |
Other | 6 | 6.7% |
Adenocarcinoma Histology: Hepatic (n = 75) | 61 | 81% |
Lung (n = 15) | 7 | 47% |
Primary for Adenocarcinoma histology | 68 | |
Colorectal | 57 | 84% |
Breast | 8 | 12% |
Gastric | 1 | 1.5% |
Lung | 1 | 1.5% |
Kidney | 1 | 1.5% |
Primary for squamous cell histology : | 7 | |
Esophagus | 5 | 71% |
Lung | 2 | 29% |
Other histologies : | 15 | 17% |
Lesions : Lung | 15 | 17% |
Hepatic | 75 | 83% |
Number of lesions treated by patient : | ||
1 | 64 | 71% |
2 | 19 | 21% |
3 | 4 | 4% |
4 | 3 | 3% |
Timing of Metastases: | ||
At initial diagnostic | 43 | 49% |
Within one year | 20 | 23% |
More than 1 year | 25 | 28% |
Time from diagnosis of metastasis to SBRT treatment, median (range) | 25.6 months | (1.2 – 93.6) |
Previous local treatment : | ||
Hepatic (n = 75) | 53 | 71% |
Lung (n = 15) | 0 | 0% |
Prior chemotherapy: | 91% | |
Hepatic lesions (n = 75) | 70 | 93% |
Lung lesions (n = 15) | 12 | 92% |
Prior progressive disease with Chemo: | ||
No | 67 | 82% |
Yes | 15 | 18% |
More than 3 chemotherapy regimens before SBRT : | 26,6% | |
Hepatic lesions (n = 75) | 21 | 28% |
Lung lesions (n = 15) | 3 | 20% |